Cargando…
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
Hodgkin Lymphoma (HL) is a unique disease entity both in its pathology and the young patient population that it primarily affects. Although cure rates are high, survivorship can be linked with significant long-term morbidity associated with both chemotherapy and radiotherapy. The most significant re...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025119/ https://www.ncbi.nlm.nih.gov/pubmed/29914088 http://dx.doi.org/10.3390/cancers10060204 |